We’re pleased to report that our newest client, New Ventures, of Virginia Beach, VA., has closed a $90 M fund focused on innovative companies in healthcare and digital medicine.  The venture platform, which targets companies that accelerate the industry, closed June 15, 2019. The fund has made twelve investments thus far. New Ventures III follows in the footsteps of the two previous funds, New Ventures I and New Ventures Select, which focused on investments in a diversified portfolio of early to mid-stage therapeutics, digital medicine opportunities, and pharmaceutical royalties.

More information is available in a press release we posted  on Business Wire.

–Anita M. Harris